23andMe Sells Customer DNA Data to GlaxoSmithKline

23andMe Sells Customer DNA Data to GlaxoSmithKline

It was recently reported that DNA testing company 23andMe had shared its DNA data with the world’s ninth-largest pharmaceutical company, GlaxoSmithKline (GSK).

In a four-year agreement pioneered by scientists Hal Barron and Richard Scheller, 23andMe sold a $300-million stake while and GSK gets exclusive access to one of the world’s largest private genetic databases.

CEO Anne Wokcicki clarifies that new customers have the choice not to include their data in future trials, and existing customers can opt-out at any time.

Source: Vice

Disini & Disini Law Office
info@privacy.com.ph